No Recent News for the Company
Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015: Intimation Regarding Receipt Of An Order From Office Of The Asst. / Dy. Commissioner Of (CGST & C. Ex.) Division-IV Palghar Commissionerate
31-Mar-2026 | Source : BSEEnclosed.
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
28-Mar-2026 | Source : BSEThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on March 27 2026 for Ashish Subhash Dandekar
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
27-Mar-2026 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 27 2026 for Ashish Dandekar
Corporate Actions
No Upcoming Board Meetings
Camlin Fine Sciences Ltd has declared 45% dividend, ex-date: 28 Jul 16
Camlin Fine Sciences Ltd has announced 1:2 stock split, ex-date: 04 Sep 14
No Bonus history available
Camlin Fine Sciences Ltd has announced 5:41 rights issue, ex-date: 08 Jan 25